Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Atossa Therapeutics Inc (NASDAQ: ATOS) closed the day trading at $0.85 down -2.54% from the previous closing price of $0.87. In other words, the price has decreased by -$2.54 from its previous closing price. On the day, 0.55 million shares were traded. ATOS stock price reached its highest trading level at $0.88 during the session, while it also had its lowest trading level at $0.85.
Ratios:
For a better understanding of ATOS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.30 and its Current Ratio is at 13.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 10 ’24 when Finn Jonathan bought 25,000 shares for $1.77 per share. The transaction valued at 44,250 led to the insider holds 25,000 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 107257928 and an Enterprise Value of 32492150.
Stock Price History:
The Beta on a monthly basis for ATOS is 1.25, which has changed by 0.03571427 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $2.31, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is -20.23%, while the 200-Day Moving Average is calculated to be -34.85%.
Shares Statistics:
Over the past 3-months, ATOS traded about 858.51K shares per day on average, while over the past 10 days, ATOS traded about 830150 shares per day. A total of 125.80M shares are outstanding, with a floating share count of 125.75M. Insiders hold about 0.04% of the company’s shares, while institutions hold 21.90% stake in the company. Shares short for ATOS as of 1736899200 were 8735726 with a Short Ratio of 10.18, compared to 1734048000 on 8198158. Therefore, it implies a Short% of Shares Outstanding of 8735726 and a Short% of Float of 6.950000000000001.
Earnings Estimates
A detailed examination of Atossa Therapeutics Inc (ATOS) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.21 and -$0.22 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.27, with 3.0 analysts recommending between -$0.25 and -$0.29.
